(S1 (S (NP (NN PTX)) (VP (VBZ upregulates) (NP (NP (NN CREB) (NN phosphorylation)) (CC and) (NP (NN activation))) (PP (IN after) (NP (NN LPS) (NN stimulation))))))
(S1 (S (S (NP (NP (NN Phosphorylation)) (PP (IN of) (NP (JJ nuclear) (NN CREB)))) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NN marker)) (PP (IN for) (NP (NN CREB) (NN activation)))))))) (. .)))
(S1 (S (S (NP (NN LPS) (NN stimulation)) (VP (VBD caused) (NP (NP (DT a) (JJ negligible) (NN increase)) (PP (IN in) (NP (NN CREB) (NN phosphorylation)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NP (NN control)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4A)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (NP (NN PTX)) (ADVP (RB alone)) (VP (VBD caused) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (NP (NN CREB) (NN phosphorylation)) (PRN (-LRB- -LRB-) (NP (NP (NN P) (NN <) (CD 0.01)) (CC vs.) (NP (NN HBSS))) (-RRB- -RRB-))))))) (. .)))
(S1 (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN LPS)) (CC and) (NP (NN PTX) (NN exposure))) (VP (VBD occurred) (ADVP (RB simultaneously))))) (, ,) (NP (NN CREB) (NN phosphorylation)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN than) (PP (IN with) (NP (NP (NN LPS) (NN stimulation)) (ADVP (RB alone))))))) (PRN (-LRB- -LRB-) (QP (QP (CD 543) (CC +/-) (CD 92)) (CC vs.) (QP (CD 100) (CC +/-) (CD 0))) (: ;) (NP (NP (NN P)) (QP (RB <) (CD 0.01))) (-RRB- -RRB-)) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN CREB) (NN phosphorylation))) (VP (VBN seen) (PP (IN with) (NP (JJ concomitant) (NN LPS) (CC and) (NN PTX) (NN treatment))))) (VP (VBD was) (ADJP (RBR less) (PP (IN than) (NP (NP (DT that)) (VP (VBN seen) (PP (IN with) (NP (NP (NN PTX)) (ADVP (RB alone)))))))) (, ,) (SBAR (IN although) (S (NP (DT this) (NN difference)) (VP (VBD was) (RB not) (ADJP (RB statistically) (JJ significant) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (ADJP (JJ =) (NP (CD 0.08)))) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN if) (S (NP (NN CREB-DNA) (NN binding)) (VP (VBD was) (VP (VBN affected) (PP (IN by) (NP (NN PTX))) (PP (IN in) (NP (NP (DT a) (NN manner)) (ADJP (JJ similar) (PP (TO to) (NP (NN CREB) (NN phosphorylation))))))))))))) (, ,) (NP (DT an) (NN EMSA)) (VP (VBD was) (VP (VBN performed)))) (. .)))
(S1 (S (S (NP (NP (NN Exposure)) (PP (IN of) (NP (JJ LPS-stimulated) (NNS cells))) (PP (TO to) (NP (NN PTX)))) (ADVP (RB similarly)) (VP (VBD increased) (NP (NN CREB) (NN DNA-binding)) (PP (VBN compared) (PP (TO to) (NP (NP (NP (NN LPS)) (ADVP (RB alone))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4B)) (-RRB- -RRB-))))))) (. .)))
